Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
The Journal of Biological Chemistry|June 1, 2002
Determinants of vascular permeability in the kidney glomerulusYuki Hamano, James A Grunkemeyer, Akulapalli Sudhakar, et al.Blood|April 12, 2007
Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesisChandra Shekhar Boosani, Arjuna P Mannam, Dominic Cosgrove, et al.The American Journal of Pathology|July 28, 2004
Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injuryXiwu Chen, Gilbert Moeckel, Jason D Morrow, et al.Kidney International|May 12, 2016
Endothelin A receptor activation on mesangial cells initiates Alport glomerular diseaseBrianna Dufek, Daniel T Meehan, Duane Delimont, et al.International Journal of Obesity (2005)|September 24, 2025
Ototoxic impacts of adipose-derived extracts on a murine auditory cell line: molecular insights from proteomic analysesAppolinaire A Olou, Wesley Tom, Gary Krzyzanowski, et al.Kidney International|March 13, 2003
Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosisKathyrn D Rodgers, Velidi Rao, Daniel T Meehan, et al.International Journal of Molecular Sciences|May 4, 2026
A Whole-Exome Sequencing-Based Exploration of Chronic Kidney Disease of Unknown Etiology (CKDu) in an Endemic Population in Sri LankaWesley Tom, Chiran Weerakoon, Nirmalee Fernando, et al.Science Advances|December 3, 2020
BRAF inhibition protects against hearing loss in miceMatthew A Ingersoll, Emma A Malloy, Lauryn E Caster, et al.Nature Communications|February 22, 2023
The usherin mutation c.2299delG leads to its mislocalization and disrupts interactions with whirlin and VLGR1Lars Tebbe, Maggie L Mwoyosvi, Ryan Crane, et al.Plos Medicine|March 3, 2006
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney diseaseMichael Zeisberg, Mona Khurana, Velidi H Rao, et al.Pageof 7